$MYGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MYRIAD GENETICS INC. Get notifications about new insider transactions in MYRIAD GENETICS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 23 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 4,328 | 161,595 | 48,128 | 52.5 K to 48.1 K (-8.25 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 23.11 | 4,328 | 100,020 | 52,456 | 48.1 K to 52.5 K (+8.99 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 1 | 37 | 48,128 | 48.1 K to 48.1 K (0.00 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 16.53 | 1 | 17 | 48,129 | 48.1 K to 48.1 K (0.00 %) |
| Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 8,790 | 264,755 | 0 | |
| Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.98 | 8,790 | 333,844 | 48,128 | 56.9 K to 48.1 K (-15.44 %) |
| Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 8,790 | 264,755 | 56,918 | 48.1 K to 56.9 K (+18.26 %) |
| Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Grant | A | 0.00 | 32,000 | 0 | 32,801 | 801 to 32.8 K (+3,995.01 %) |
| Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K |
| Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Grant | A | 0.00 | 25,000 | 0 | 26,193 | 1.2 K to 26.2 K (+2,095.56 %) |
| Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 46,000 | 0 | 50,698 | 4.7 K to 50.7 K (+979.14 %) |
| Sep 18 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Grant | A | 0.00 | 25,000 | 0 | 25,844 | 844 to 25.8 K (+2,962.09 %) |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 9.04 | 24,000 | 216,960 | 48,000 | |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 39.50 | 24,000 | 948,000 | 6,540 | 30.5 K to 6.5 K (-78.59 %) |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 9.04 | 24,000 | 216,960 | 30,540 | 6.5 K to 30.5 K (+366.97 %) |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 8,544 | 0 | 6,540 | 15.1 K to 6.5 K (-56.64 %) |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 18.06 | 20,000 | 361,200 | 10,000 | |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.85 | 20,000 | 797,082 | 14,551 | 34.6 K to 14.6 K (-57.89 %) |
| Jul 15 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 18.06 | 20,000 | 361,200 | 34,551 | 14.6 K to 34.6 K (+137.45 %) |
| Jun 06 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 7.60 | 5,000 | 38,000 | 0 | |
| Jun 06 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 35.70 | 5,000 | 178,511 | 4,000 | 9 K to 4 K (-55.56 %) |
| Jun 06 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 7.60 | 5,000 | 38,000 | 9,000 | 4 K to 9 K (+125.00 %) |
| May 09 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Option Exercise | M | 25.12 | 8,520 | 214,022 | 25,560 | |
| May 09 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Option Exercise | M | 25.12 | 3,980 | 99,978 | 11,940 | |
| May 09 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Sell | S | 36.01 | 3,980 | 143,320 | 0 | 4 K to 0 (-100.00 %) |
| May 09 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Buy | M | 25.12 | 3,980 | 99,978 | 3,980 | 0 to 4 K |
| May 09 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Sell | S | 36.01 | 8,520 | 306,805 | 0 | 8.5 K to 0 (-100.00 %) |
| May 09 2014 | MYGN | MYRIAD GENETICS IN ... | Rogers Ronald S. | Exec VP Corp Commun ... | Buy | M | 25.12 | 8,520 | 214,022 | 8,520 | 0 to 8.5 K |
| May 01 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 13.28 | 30,000 | 398,400 | 0 | |
| May 01 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 41.80 | 30,000 | 1,254,000 | 18,285 | 48.3 K to 18.3 K (-62.13 %) |
| May 01 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 13.28 | 30,000 | 398,400 | 48,285 | 18.3 K to 48.3 K (+164.07 %) |
| Apr 25 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 18.06 | 31,516 | 569,179 | 0 | |
| Apr 25 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 39.80 | 31,516 | 1,254,337 | 18,285 | 49.8 K to 18.3 K (-63.28 %) |
| Apr 25 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 18.06 | 31,516 | 569,179 | 49,801 | 18.3 K to 49.8 K (+172.36 %) |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 18.06 | 28,484 | 514,421 | 31,516 | |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 39.80 | 28,484 | 1,133,663 | 18,285 | 46.8 K to 18.3 K (-60.90 %) |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 18.06 | 28,484 | 514,421 | 46,769 | 18.3 K to 46.8 K (+155.78 %) |
| Apr 17 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 3,208 | 0 | 18,285 | 21.5 K to 18.3 K (-14.93 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 27.07 | 17,500 | 473,725 | 51,907 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 24.89 | 21,966 | 546,734 | 21,966 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 23.98 | 3,500 | 83,930 | 7,000 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 19.47 | 28,000 | 545,160 | 28,000 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Option Exercise | M | 24.89 | 8,034 | 199,966 | 8,034 | |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 8,034 | 328,566 | 930 | 9 K to 930 (-89.63 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 24.89 | 8,034 | 199,966 | 8,964 | 930 to 9 K (+863.87 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 21,966 | 898,344 | 930 | 22.9 K to 930 (-95.94 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 24.89 | 21,966 | 546,734 | 22,896 | 930 to 22.9 K (+2,361.94 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 28,000 | 1,145,116 | 930 | 28.9 K to 930 (-96.79 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 19.47 | 28,000 | 545,160 | 28,930 | 930 to 28.9 K (+3,010.75 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 3,500 | 143,140 | 930 | 4.4 K to 930 (-79.01 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 23.98 | 3,500 | 83,930 | 4,430 | 930 to 4.4 K (+376.34 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | S | 40.90 | 17,500 | 715,698 | 930 | 18.4 K to 930 (-94.95 %) |
| Apr 07 2014 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Buy | M | 27.07 | 17,500 | 473,725 | 18,430 | 930 to 18.4 K (+1,881.72 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.34 | 76,139 | 2,310,057 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.34 | 3,861 | 117,143 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 40.00 | 3,861 | 154,440 | 47,609 | 51.5 K to 47.6 K (-7.50 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.34 | 3,861 | 117,143 | 51,470 | 47.6 K to 51.5 K (+8.11 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 40.00 | 76,139 | 3,045,560 | 47,609 | 123.7 K to 47.6 K (-61.53 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.34 | 76,139 | 2,310,057 | 123,748 | 47.6 K to 123.7 K (+159.93 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 18.06 | 30,000 | 541,800 | 30,000 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 13.28 | 54,676 | 726,097 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.65 | 54,676 | 2,167,701 | 14,551 | 69.2 K to 14.6 K (-78.98 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 13.28 | 54,676 | 726,097 | 69,227 | 14.6 K to 69.2 K (+375.75 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.65 | 5,324 | 211,077 | 14,551 | 19.9 K to 14.6 K (-26.79 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 13.28 | 5,324 | 70,703 | 19,875 | 14.6 K to 19.9 K (+36.59 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.80 | 30,000 | 1,194,066 | 14,551 | 44.6 K to 14.6 K (-67.34 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 18.06 | 30,000 | 541,800 | 44,551 | 14.6 K to 44.6 K (+206.17 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.65 | 3,000 | 118,939 | 14,551 | 17.6 K to 14.6 K (-17.09 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 30.12 | 55,000 | 1,656,600 | 52,654 | |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 39.57 | 55,000 | 2,176,350 | 15,084 | 70.1 K to 15.1 K (-78.48 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 30.12 | 55,000 | 1,656,600 | 70,084 | 15.1 K to 70.1 K (+364.62 %) |
| Apr 04 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 11,000 | 0 | 15,084 | 26.1 K to 15.1 K (-42.17 %) |
| Mar 31 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
| Mar 31 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 23.11 | 4,328 | 100,020 | 21,493 | 17.2 K to 21.5 K (+25.21 %) |
| Mar 20 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 30.12 | 55,000 | 1,656,600 | 107,654 | |
| Mar 20 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 37.00 | 55,000 | 2,035,000 | 26,084 | 81.1 K to 26.1 K (-67.83 %) |
| Mar 20 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 30.12 | 55,000 | 1,656,600 | 81,084 | 26.1 K to 81.1 K (+210.86 %) |
| Mar 19 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 30.12 | 55,000 | 1,656,600 | 162,654 | |
| Mar 19 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 35.15 | 55,000 | 1,933,305 | 26,084 | 81.1 K to 26.1 K (-67.83 %) |
| Mar 19 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 30.12 | 55,000 | 1,656,600 | 81,084 | 26.1 K to 81.1 K (+210.86 %) |
| Mar 19 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 29,572 | 0 | 26,084 | 55.7 K to 26.1 K (-53.13 %) |
| Mar 13 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 9.04 | 50,000 | 452,000 | 0 | |
| Mar 13 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 34.37 | 50,000 | 1,718,290 | 17,165 | 67.2 K to 17.2 K (-74.44 %) |
| Mar 13 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 9.04 | 50,000 | 452,000 | 67,165 | 17.2 K to 67.2 K (+291.29 %) |
| Mar 11 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 7.60 | 20,000 | 152,000 | 5,000 | |
| Mar 11 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 37.86 | 20,000 | 757,196 | 4,000 | 24 K to 4 K (-83.33 %) |
| Mar 11 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 7.60 | 20,000 | 152,000 | 24,000 | 4 K to 24 K (+500.00 %) |
| Mar 07 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 7.60 | 5,000 | 38,000 | 25,000 | |
| Mar 07 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 37.59 | 5,000 | 187,935 | 4,000 | 9 K to 4 K (-55.56 %) |
| Mar 07 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 7.60 | 5,000 | 38,000 | 9,000 | 4 K to 9 K (+125.00 %) |
| Feb 26 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 24.40 | 30,000 | 732,000 | 0 | |
| Feb 26 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 37.58 | 30,000 | 1,127,319 | 0 | 30 K to 0 (-100.00 %) |
| Feb 26 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 24.40 | 30,000 | 732,000 | 30,000 | 0 to 30 K |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 19.47 | 64,000 | 1,246,080 | 144,000 | |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 18.00 | 31,250 | 562,500 | 25,695 | |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 37.83 | 31,250 | 1,182,188 | 48,268 | 79.5 K to 48.3 K (-39.30 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 18.00 | 31,250 | 562,500 | 79,518 | 48.3 K to 79.5 K (+64.74 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 37.83 | 64,000 | 2,421,120 | 48,268 | 112.3 K to 48.3 K (-57.01 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 19.47 | 64,000 | 1,246,080 | 112,268 | 48.3 K to 112.3 K (+132.59 %) |
| Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 20,000 | 360,000 | 34,445 | |
| Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.00 | 20,000 | 760,000 | 2,949 | 22.9 K to 2.9 K (-87.15 %) |
| Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 20,000 | 360,000 | 22,949 | 2.9 K to 22.9 K (+678.20 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 25,000 | 372,000 | 48,120 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 34.74 | 25,000 | 868,550 | 2,949 | 27.9 K to 2.9 K (-89.45 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 25,000 | 372,000 | 27,949 | 2.9 K to 27.9 K (+847.74 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 12.17 | 5,236 | 63,722 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 18.06 | 2,230 | 40,274 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 12.17 | 4,764 | 57,978 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 5,236 | 189,632 | 324 | 5.6 K to 324 (-94.17 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 12.17 | 5,236 | 63,722 | 5,560 | 324 to 5.6 K (+1,616.05 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 4,764 | 172,538 | 324 | 5.1 K to 324 (-93.63 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 12.17 | 4,764 | 57,978 | 5,088 | 324 to 5.1 K (+1,470.37 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 2,230 | 80,764 | 324 | 2.6 K to 324 (-87.31 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 18.06 | 2,230 | 40,274 | 2,554 | 324 to 2.6 K (+688.27 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 5,324 | 192,819 | 324 | 5.6 K to 324 (-94.26 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 13.28 | 5,324 | 70,703 | 5,648 | 324 to 5.6 K (+1,643.21 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Option Exercise | M | 21.29 | 30,000 | 638,700 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Sell | S | 35.00 | 30,000 | 1,050,000 | 0 | 30 K to 0 (-100.00 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Buy | M | 21.29 | 30,000 | 638,700 | 30,000 | 0 to 30 K |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.27 | 30,000 | 218,100 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 36.01 | 30,000 | 1,080,375 | 47,609 | 77.6 K to 47.6 K (-38.66 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.27 | 30,000 | 218,100 | 77,609 | 47.6 K to 77.6 K (+63.01 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 21.66 | 30,000 | 649,800 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 21.29 | 30,000 | 638,700 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 34.48 | 30,000 | 1,034,310 | 0 | 30 K to 0 (-100.00 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 21.66 | 30,000 | 649,800 | 30,000 | 0 to 30 K |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 34.48 | 30,000 | 1,034,310 | 0 | 30 K to 0 (-100.00 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 21.29 | 30,000 | 638,700 | 30,000 | 0 to 30 K |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 13.28 | 10,000 | 132,800 | 54,676 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 12.17 | 24,192 | 294,417 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 34.55 | 24,192 | 835,754 | 17,551 | 41.7 K to 17.6 K (-57.95 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 12.17 | 24,192 | 294,417 | 41,743 | 17.6 K to 41.7 K (+137.84 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 34.55 | 10,000 | 345,467 | 17,551 | 27.6 K to 17.6 K (-36.30 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 13.28 | 10,000 | 132,800 | 27,551 | 17.6 K to 27.6 K (+56.98 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 13.28 | 34,676 | 460,497 | 30,000 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 34.71 | 34,676 | 1,203,736 | 17,165 | 51.8 K to 17.2 K (-66.89 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 13.28 | 34,676 | 460,497 | 51,841 | 17.2 K to 51.8 K (+202.02 %) |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 7.82 | 20,960 | 163,907 | 0 | |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 31.50 | 20,960 | 660,223 | 17,165 | 38.1 K to 17.2 K (-54.98 %) |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 7.82 | 20,960 | 163,907 | 38,125 | 17.2 K to 38.1 K (+122.11 %) |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 4,196 | 0 | 17,165 | 21.4 K to 17.2 K (-19.64 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 7.82 | 2,500 | 19,550 | 0 | |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 7.82 | 7,500 | 58,650 | 2,500 | |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 6.00 | 506 | 3,036 | 0 | |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.72 | 3,201 | 98,344 | 324 | 3.5 K to 324 (-90.81 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.74 | 506 | 15,557 | 3,525 | 4 K to 3.5 K (-12.55 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 6.00 | 506 | 3,036 | 4,031 | 3.5 K to 4 K (+14.35 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.74 | 2,500 | 76,861 | 3,525 | 6 K to 3.5 K (-41.49 %) |